
X
Drawing strength from growing up with LHON
https://pharmaphorum.com/disease-spotlight/drawing-strength-from-growing-up-with-lhon/
Swiss company to appeal regulators’ decision.
Patients to get Santhera’s Raxone under EAMS scheme.
Approval unlikely before 2020.